Upcoming Webinars:

Register Here!

GastroPlus® v9.8.1 DDI Standards Update and Documentation Project

IPFsym™, a platform to support the development of effective treatments for IPF patients

Watch Past Webinars

What’s New in GastroPlus v9.8.2?

The latest version of GastroPlus® has the most innovative & integrative software improvements to accelerate drug development through continued collaborations with several large pharmaceutical companies and the U.S. FDA!

Stream Download

What’s new in MonolixSuite 2021

Watch out for the release of MonolixSuite 2021!


PBPK Modeling Approach in Pregnant Subjects and Fetus

PBPK modeling gives birth to a new application!

Stream Download

Developing a PBPK modeling approach for evaluating drug product performance in infants based on adults data

Understanding drug and drug formulation performance in relation to the prandial conditions is essential for ensuring the safety and efficacy of products to be administered to pediatric patients, especially newborns...

Stream Download

ADMET Predictor® 10.3 (APX.3): Flagship machine learning platform for ADMET modeling

Panelist David Miller, VP of ADMET Cheminformatics will show some of the new features in APX.3, including details about a new REST API for deployment via Web services.

Stream Download

Real-world Considerations in Pharma for QSP Modeling

Quantitative systems pharmacology (QSP) modeling enables better drug development decisions through a more advanced understanding of the disease area of inter

Stream Download

Introducing, IPFsym™ the QSP modeling software for idiopathic pulmonary fibrosis

IPFsym® is a mechanistic, mathematical model for QSP of idiopathic pulmonary fibrosis (IPF) that can be used to predict efficacy for potential treatments.

Stream Download

Culture & Conversation – The accelerator pedal for innovation…

The central idea behind the “learn and confirm” paradigm is to emphasize the learning part of R&D and then intelligently apply what has been learned to the design of clinical trials.

Stream Download

Best Practices for Membrane & Biphasic In Vitro Dissolution with DDDPlus™ & GastroPlus®

DDDPlus is a state-of-the-art simulation platform for in vitro dissolution.

Stream Download

Simulx Webinar: Optimizing Sample Size of a Phase III trial

What if we could reduce the size of a phase III study from 400 to 80 subjects and make it twice as short? Thanks to model-informed clinical trial design, it's possible!